The Effects of Patient Features on Opioid Induced End-Tidal CO2 (Capno)

This study is currently recruiting participants.

Verified June 2011 by Albany Medical College

Sponsor:

Information provided by:

Albany Medical College

ClinicalTrials.gov Identifier:

NCT01371903

First received: June 10, 2011

Last updated: NA

Last verified: June 2011

History: No changes posted

Tracking Information
First Received Date ^ICMJE	June 10, 2011
Last Updated Date	June 10, 2011
Start Date ^ICMJE	August 2010
Estimated Primary Completion Date	August 2011 (final data collection date for primary outcome measure)
Current Primary Outcome Measures ^ICMJE	Not Provided
Original Primary Outcome Measures ^ICMJE	Not Provided
Change History	No Changes Posted
Current Secondary Outcome Measures ^ICMJE	Not Provided
Original Secondary Outcome Measures ^ICMJE	Not Provided
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	The Effects of Patient Features on Opioid Induced End-Tidal CO2
Official Title ^ICMJE	The Effect of Patient Features on Opioid Induced End-Tidal CO2
Brief Summary	Emergency department patients receiving opioid pain medicine such as morphine, fentanyl or Dilaudid are eligible. After medication exhaled carbon dioxide is measured. and recorded.
Detailed Description	Emergency department patients receiving opioid pain medicine such as morphine, fentanyl, or Dilaudid are eligible. After receiving the pain medication, a small soft plastic tube will be placed between the upper lip and nose. This tube is used to measure the amount of carbon dioxide the patient is breathing out. It can also be used to deliver oxygen if the provider feels the patient needs it. The carbon dioxide breathed out is measured and collected. Other information collected are height, weight, and vital signs. Patient participation time is approximately 2 hours during the emergency department visit.
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Observational Model: Cohort Time Perspective: Prospective
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Non-Probability Sample
Study Population	Patients receiving opioid such as morphine, fentanyl, or dilaudid during their emergency department visit.
Condition ^ICMJE	Opioid Use During Medical Care
Intervention ^ICMJE	Not Provided
Study Group/Cohort (s)	Not Provided
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Recruiting
Estimated Enrollment ^ICMJE	150
Estimated Completion Date	January 2012
Estimated Primary Completion Date	August 2011 (final data collection date for primary outcome measure)
Eligibility Criteria ^ICMJE	Inclusion Criteria: non intubated patients receiving intravenous opioid medications Exclusion Criteria: mechanically ventilated patients patients with physiologic shock
Gender	Both
Ages	18 Years and older
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Not Provided
Location Countries ^ICMJE	United States

Administrative Information
NCT Number ^ICMJE	NCT01371903
Other Study ID Numbers ^ICMJE	2792
Has Data Monitoring Committee	Yes
Responsible Party	Wayne Triner, DO, MPH, Albany Medical Colllege
Study Sponsor ^ICMJE	Albany Medical College
Collaborators ^ICMJE	Not Provided
Investigators ^ICMJE	Not Provided
Information Provided By	Albany Medical College
Verification Date	June 2011
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top